AbbVie (Brazil) Performance
| ABBV34 Stock | BRL 66.56 0.62 0.92% |
The firm shows a Beta (market volatility) of 0.0492, which signifies not very significant fluctuations relative to the market. As returns on the market increase, AbbVie's returns are expected to increase less than the market. However, during the bear market, the loss of holding AbbVie is expected to be smaller as well. At this point, AbbVie Inc has a negative expected return of -0.0067%. Please make sure to confirm AbbVie's market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to decide if AbbVie Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days AbbVie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental drivers, AbbVie is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
AbbVie |
AbbVie Relative Risk vs. Return Landscape
If you would invest 6,798 in AbbVie Inc on September 12, 2024 and sell it today you would lose (142.00) from holding AbbVie Inc or give up 2.09% of portfolio value over 90 days. AbbVie Inc is generating negative expected returns and assumes 2.3445% volatility on return distribution over the 90 days horizon. Simply put, 20% of stocks are less volatile than AbbVie, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
AbbVie Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AbbVie's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as AbbVie Inc, and traders can use it to determine the average amount a AbbVie's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0029
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ABBV34 |
Estimated Market Risk
| 2.34 actual daily | 20 80% of assets are more volatile |
Expected Return
| -0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average AbbVie is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AbbVie by adding AbbVie to a well-diversified portfolio.
AbbVie Fundamentals Growth
AbbVie Stock prices reflect investors' perceptions of the future prospects and financial health of AbbVie, and AbbVie fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AbbVie Stock performance.
| Return On Equity | 0.75 | |||
| Return On Asset | 0.0927 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.39 % | |||
| Current Valuation | 1.85 T | |||
| Shares Outstanding | 28.3 B | |||
| Price To Earning | 92.88 X | |||
| Price To Book | 18.25 X | |||
| Price To Sales | 26.35 X | |||
| Revenue | 58.05 B | |||
| EBITDA | 31.08 B | |||
| Cash And Equivalents | 5.23 B | |||
| Cash Per Share | 3.54 X | |||
| Total Debt | 37.92 B | |||
| Book Value Per Share | 9.04 X | |||
| Cash Flow From Operations | 13.8 B | |||
| Earnings Per Share | 2.18 X | |||
About AbbVie Performance
By analyzing AbbVie's fundamental ratios, stakeholders can gain valuable insights into AbbVie's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AbbVie has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AbbVie has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. ABBVIE DRN operates under Drug Manufacturers - Major classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 30000 people.Things to note about AbbVie Inc performance evaluation
Checking the ongoing alerts about AbbVie for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AbbVie Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AbbVie Inc generated a negative expected return over the last 90 days |
- Analyzing AbbVie's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AbbVie's stock is overvalued or undervalued compared to its peers.
- Examining AbbVie's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AbbVie's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AbbVie's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AbbVie's stock. These opinions can provide insight into AbbVie's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for AbbVie Stock analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |